Literature DB >> 23891021

Effect of single-dose methotrexate on ovarian reserve in women with ectopic pregnancy.

Ibrahim Uyar1, Onur Umut Yucel, Cenk Gezer, Ibrahim Gulhan, Buket Karis, H Merih Hanhan, Mehmet Ozeren.   

Abstract

OBJECTIVE: To evaluate ovarian reserve in women with ectopic pregnancy treated with single-dose systemic methotrexate in the early post-treatment period.
DESIGN: Prospective study.
SETTING: Women's health education and research hospital. PATIENT (S): Eighty-two patients with ectopic pregnancy and 80 healthy women in the same age group were included in the study. Of the 82 patients, 49 with ectopic pregnancy were treated with single-dose systemic methotrexate (MTX) and 33 were treated surgically with laparoscopy or laparotomy (salpingectomy or salpingostomy). INTERVENTION(S): Ovarian reserve testing. MAIN OUTCOME MEASURE(S): Basal FSH on the 3rd day of the menstrual cycle, E₂, basal antral follicle count (AFC), and ovarian volume. RESULT(S): There were no differences among the groups in terms of basal FSH, E₂, AFC, and ovarian volume. CONCLUSION(S): The single-dose MTX treatment had no effect on ovarian reserve in women with ectopic pregnancy as measured by the above-mentioned parameters.
Copyright © 2013 American Society for Reproductive Medicine. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Ovarian reserve; ectopic pregnancy; methotrexate treatment

Mesh:

Substances:

Year:  2013        PMID: 23891021     DOI: 10.1016/j.fertnstert.2013.06.040

Source DB:  PubMed          Journal:  Fertil Steril        ISSN: 0015-0282            Impact factor:   7.329


  8 in total

1.  Comparison the Results of Hysterosalpangiography in Patients with Ectopic Pregnancy Treated by Laparoscopic Salpingostomy, Laparotomy, and Treated with Methotrexate.

Authors:  Behnaz Khani; Mina Ahmadi; Safoura Rouholamin
Journal:  Adv Biomed Res       Date:  2022-03-30

2.  Methotrexate does not affect ovarian reserve or subsequent assisted reproductive technology outcomes.

Authors:  Christina E Boots; Micah J Hill; Eve C Feinberg; Ruth B Lathi; Susan A Fowler; Emily S Jungheim
Journal:  J Assist Reprod Genet       Date:  2016-03-04       Impact factor: 3.412

3.  Ovarian reserve and subsequent assisted reproduction outcomes after methotrexate therapy for ectopic pregnancy or pregnancy of unknown location.

Authors:  Micah J Hill; Janelle C Cooper; Gary Levy; Connie Alford; Kevin S Richter; Alan H DeCherney; Charles L Katz; Eric D Levens; Erin F Wolff
Journal:  Fertil Steril       Date:  2013-11-20       Impact factor: 7.329

Review 4.  Ectopic pregnancy secondary to in vitro fertilisation-embryo transfer: pathogenic mechanisms and management strategies.

Authors:  Bassem Refaat; Elizabeth Dalton; William L Ledger
Journal:  Reprod Biol Endocrinol       Date:  2015-04-12       Impact factor: 5.211

5.  Predictors of success of different treatment modalities for management of ectopic pregnancy.

Authors:  Sümeyra Nergiz Avcioğlu; Sündüz Özlem Altinkaya; Mert Küçük; Selda Demircan Sezer; Hasan Yüksel
Journal:  Obstet Gynecol Int       Date:  2014-12-14

Review 6.  Salpingectomy before assisted reproductive technologies: a systematic literature review.

Authors:  Marco Noventa; Salvatore Gizzo; Carlo Saccardi; Shara Borgato; Amerigo Vitagliano; Michela Quaranta; Pietro Litta; Michele Gangemi; Guido Ambrosini; Donato D'Antona; Stefano Palomba
Journal:  J Ovarian Res       Date:  2016-11-03       Impact factor: 4.234

Review 7.  MicroRNAs as Potential Serum Biomarkers for Early Detection of Ectopic Pregnancy.

Authors:  Emmanuel N Kontomanolis; Sofia Kalagasidou; Zacharias Fasoulakis
Journal:  Cureus       Date:  2018-03-19

8.  Effects of Methotrexate Therapy on the Levels of Gonadotropic Hormones in Rheumatoid Arthritis Patients of Reproductive Age.

Authors:  Min Tun Kyaw; Rajalingham Sakthiswary; Zainudin Ani Amelia; Abdul Rahman Rahana; Md Mansor Munirah
Journal:  Cureus       Date:  2020-04-11
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.